STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

  1. Home
  2. Sec-filings
  3. JUNS
  4. [ARS] JUPITER NEUROSCIENCES, INC. SEC Filing

[ARS] JUPITER NEUROSCIENCES, INC. SEC Filing

Filing Impact
(No impact)
Filing Sentiment
(Neutral)
Form Type
ARS
ARS - JUPITER NEUROSCIENCES, INC.

ARS Filing - JUPITER NEUROSCIENCES, INC.

This filing is available as a PDF document.

Filing Type: ARS

Company: JUPITER NEUROSCIENCES, INC. (JUNS)

Acceptance Date: 2025-11-06T07:36:27.000Z

View PDF Document

Source: View Original Filing on SEC EDGAR

Stock JUNS logo
JUPITER NEUROSCIENCES, INC.

NASDAQ:JUNS

JUNS Rankings

#5500 Ranked by Market Cap
N/A Ranked by Dividends

JUNS Latest News

Nov 5, 2025
Jupiter Neurosciences Receives FDA Clearance of IND Application to Initiate Phase 2a Clinical Trial of JOTROL™ in Parkinson’s Disease
Oct 27, 2025
Jupiter Neurosciences Enters into Agreements for up to $20 Million in Flexible Financing
Sep 15, 2025
Jupiter Neurosciences Names Visionary Entrepreneur and Biohacker Jean Fallacara as Third Nugevia™ Brand Ambassador
Aug 26, 2025
Jupiter Neurosciences Launches Nugevia™ Website and Opens Pre-Orders for Groundbreaking Longevity Supplements
Aug 19, 2025
Jupiter Neurosciences Names NBA Legend Chris Webber as Second Nugevia™ Brand Ambassador

JUNS Latest SEC Filings

Nov 6, 2025
[DEF 14A] JUPITER NEUROSCIENCES, INC. Definitive Proxy Statement
Oct 27, 2025
[PRER14A] JUPITER NEUROSCIENCES, INC. Preliminary Revised Proxy Statement
Oct 27, 2025
[8-K] JUPITER NEUROSCIENCES, INC. Reports Material Event
Oct 17, 2025
[PRE 14A] JUPITER NEUROSCIENCES, INC. Preliminary Proxy Statement
Aug 14, 2025
[NT 10-Q] Jupiter Neurosciences, Inc. SEC Filing

JUNS Stock Data

46.33M
15.73M
54.65%
0.23%
0.54%
Biotechnology
Pharmaceutical Preparations
Link
United States
JUPITER